Paul Thompsonpaul.thompson@PAREXEL.com+1 781 434 4015
Biosimilar overview
Biosimilar development and marketing
More on Biosimilars
Biosimilars Whitepaper
Biosimilars: What lies ahead?
Biosimilars: Growing the Concept
Lessons Learned From EU Biosimilar Development
Fresh Insights Into the Practicalities of Developing Biosimilar Biologics
Phase I - IV clinical trials management and biostatistics, data management and clinical pharmacology, as well as related medical advisory and investigator site services.
Karen WillsKaren.Wills@PAREXEL.com+1 781 434 5301